6-氯吡啶并[3,2-B]吡嗪 | 68236-03-3

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶吡嗪类
• 中文名称: 6-氯吡啶并[3,2-B]吡嗪
• 中文别名: 6-氯吡啶并[3,2-b]吡嗪
• 英文名称: 6-Chlor-pyrido<2,3-b>pyrazin
• 英文别名: 6-Chloropyrido[2,3-b]pyrazine
• CAS: 68236-03-3
• 化学式: C₇H₄ClN₃
• mdl: MFCD11518952
• 分子量: 165.582
• InChiKey: WHKACFUJNYOJPD-UHFFFAOYSA-N

物化性质

• 熔点：
  159 °C(Solv: ligroine (8032-32-4))
• 沸点：
  286.4±35.0 °C(Predicted)
• 密度：
  1.437±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.7
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 6-Chloropyrido[3,2-b]pyrazine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 6-Chloropyrido[3,2-b]pyrazine
CAS number: 68236-03-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H4ClN3
Molecular weight: 165.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-氯吡啶并[3,2-B]吡嗪 在 四(三苯基膦)钯 、 potassium carbonate 作用下， 以 水 为溶剂， 反应 32.0h， 生成 2-(4-pyrido[2,3-b]pyrazin-6-ylpyridin-1-ium-1-yl)ethanesulfonate
  参考文献：
  名称：

  [EN] HERBICIDAL COMPOUNDS
  [FR] COMPOSÉS HERBICIDES

  摘要：

  式（I）中的化合物，其中取代基如权利要求1中定义的那样，作为农药是有用的，特别是作为除草剂。

  公开号：

  WO2021058592A1
• 作为产物：
  描述：

  6-氯-2,3-二氨基吡啶 、 草酸醛 在 四氢呋喃 、 乙酸乙酯 、 disodium;carbonate 、 magnesium sulfate 、 Intermediate 4.2 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以to give 1.15 g of the expected compound as a white solid (Intermediate 4.2)的产率得到6-氯吡啶并[3,2-B]吡嗪
  参考文献：
  名称：

  Pyridine Methylene Azolidinones and Use Thereof Phosphoinositide Inhibitors

  摘要：

  本发明涉及公式（I）的融合吡啶亚甲基氮杂环酮衍生物，特别用于治疗和/或预防自身免疫性疾病和/或炎症性疾病、心血管疾病、神经退行性疾病、细菌或病毒感染、肾脏疾病、血小板聚集、癌症、移植、移植排斥或肺损伤。

  公开号：

  US20080269227A1

文献信息

• [EN] CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS<br/>[FR] CYANOGUANIDINES ET LEUR UTILISATION COMME AGENTS ANTIVIRAUX
  申请人：ABBVIE INC

  公开号：WO2014005129A1

  公开（公告）日：2014-01-03

  This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

  这份披露涉及：(a) 抑制RSV感染和/或复制的化合物及其盐，等等；(b) 用于制备这些化合物和盐的中间体；(c) 包含这些化合物和盐的组合物；(d) 制备这些中间体、化合物、盐和组合物的方法；(e) 使用这些化合物、盐和组合物的方法；以及(f) 包含这些化合物、盐和组合物的试剂盒。
• [EN] PYRIDINE METHYLENE AZOLIDINONES AND USE THEREOF PHOSPHOINOSITIDE INHIBITORS<br/>[FR] AZOLIDINONES DE METHYLENE DE PYRIDINE ET INHIBITEURS DE LA PHOSPHOINOSITIDE
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2006024666A1

  公开（公告）日：2006-03-09

  The present invention is related to fused pyridine methylene azolidinone derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

  本发明涉及特定用于治疗和/或预防自身免疫性疾病和/或炎症性疾病、心血管疾病、神经退行性疾病、细菌或病毒感染、肾脏疾病、血小板聚集、癌症、移植、移植排斥或肺损伤的融合吡啶甲亚氨基甲酮衍生物（I）的发明。
• NOVEL PYRIDOPYRAZINE DERIVATIVES, PROCESS OF MANUFACTURING AND USES THEREOF
  申请人：Gerlach Matthias

  公开号：US20090275534A1

  公开（公告）日：2009-11-05

  The invention relates to pyrido[2,3-b]pyrazine compounds of general formulae (Ia) and (Ib), to their preparation and use, for example, for the treatment of malignant disorders and other disorders based on pathological cell proliferations.

  本发明涉及一般式(Ia)和(Ib)的吡啶并[2,3-b]吡嗪类化合物，以及它们的制备和用途，例如用于治疗恶性疾病和其他基于病理细胞增殖的疾病。
• Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
  申请人：Merck Serono SA

  公开号：US08058289B2

  公开（公告）日：2011-11-15

  The present invention is related to pyridine methylene azolidinone derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

  本发明涉及式(I)的吡啶亚甲基氮杂环酮衍生物，特别用于治疗和/或预防自身免疫性疾病和/或炎症性疾病、心血管疾病、神经退行性疾病、细菌或病毒感染、肾脏疾病、血小板聚集、癌症、移植、移植排斥或肺部损伤。
• METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS
  申请人：Merck Patent GmbH

  公开号：US20150105843A1

  公开（公告）日：2015-04-16

  The present invention relates inter alia to a new class of heteroleptic metal complexes comprising condensed aromatic heterocyclic rings, their preparation and use.

  本发明涉及一种新的杂叶立德金属配合物类，包括紧凑的芳香杂环环，其制备和使用。

表征谱图